JCC: The use of metformin reduces the risk of inflammatory bowel disease in people with type 2 diabetes.

In the past two years, more and more studies have found that metformin not only has the effect of lowering blood sugar, but also anti-aging anti-tumor prolongation of life and so on.
recent research has found that he can also bring positive energy to gut bacteria, reducing the risk of inflammatory bowel disease.
Professor Guanggang, president of the World Microeconceive Society, has said that intestinal disease is the "source of all diseases";
and bad gut bacteria are like barren rivers filled with garbage and toxic substances, making trees leafy and yellow, and in people they are shown to suffer from many diseases.
study, published recently in Journal of Crohn's and Colitis, looked at the incidence of inflammatory bowel disease in diabetic patients taking metformin for a long time.
the study, researchers followed 340,211 patients who had used metformin and 24,478 patients who had never used metformin.
the danger ratio through Cox's regression.
6,466 IBD cases were diagnosed in patients who had never used metformin, and 750 IBD cases were diagnosed in patients who had never used metformin.
412.0 and 741.3 per 100,000 people per year, respectively, and the risk ratio of metformin used was 0.55 (95 per cent confidence interval: 0.51-0.60).
, the combined results found a significant reduction in IBD risk in patients with type 2 diabetes treated with metformin.
.